Cargando…

The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation

The aim of this study was to develop a predictive score for moderate-severe chronic graft-versus-host disease (cGVHD) on day +100 after allogeneic stem cell transplantation (HSCT). We studied 1292 patients allografted between 1990 and 2016, alive on day +100 after transplant, without cGVHD, and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Metafuni, Elisabetta, Cavattoni, Irene Maria, Lamparelli, Teresa, Raiola, Anna Maria, Ghiso, Anna, Galaverna, Federica, Gualandi, Francesca, Di Grazia, Carmen, Dominietto, Alida, Varaldo, Riccardo, Signori, Alessio, Chiusolo, Patrizia, Sora’, Federica, Giammarco, Sabrina, Laurenti, Luca, Sica, Simona, Angelucci, Emanuele, Bacigalupo, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006267/
https://www.ncbi.nlm.nih.gov/pubmed/34920451
http://dx.doi.org/10.1182/bloodadvances.2021005675
_version_ 1784686629785436160
author Metafuni, Elisabetta
Cavattoni, Irene Maria
Lamparelli, Teresa
Raiola, Anna Maria
Ghiso, Anna
Galaverna, Federica
Gualandi, Francesca
Di Grazia, Carmen
Dominietto, Alida
Varaldo, Riccardo
Signori, Alessio
Chiusolo, Patrizia
Sora’, Federica
Giammarco, Sabrina
Laurenti, Luca
Sica, Simona
Angelucci, Emanuele
Bacigalupo, Andrea
author_facet Metafuni, Elisabetta
Cavattoni, Irene Maria
Lamparelli, Teresa
Raiola, Anna Maria
Ghiso, Anna
Galaverna, Federica
Gualandi, Francesca
Di Grazia, Carmen
Dominietto, Alida
Varaldo, Riccardo
Signori, Alessio
Chiusolo, Patrizia
Sora’, Federica
Giammarco, Sabrina
Laurenti, Luca
Sica, Simona
Angelucci, Emanuele
Bacigalupo, Andrea
author_sort Metafuni, Elisabetta
collection PubMed
description The aim of this study was to develop a predictive score for moderate-severe chronic graft-versus-host disease (cGVHD) on day +100 after allogeneic stem cell transplantation (HSCT). We studied 1292 patients allografted between 1990 and 2016, alive on day +100 after transplant, without cGVHD, and with full biochemistry laboratory values available. Patients were randomly assigned to a training and a validation cohort (ratio 1:1). In the training cohort, a multivariate analysis identified 4 independent predictors of moderate-severe cGVHD: gamma-glutamyl transferase ≥75 UI/l, creatinine ≥1 mg/dl, cholinesterase ≤4576 UI/l, and albumin ≤4 g/dl. A score of 1 was assigned to each variable, producing a low (0 to 1), intermediate (2 to 3), and high (4) score. The cumulative incidence of moderate-severe cGVHD was 12%, 20%, and 52% (P < .0001) in the training cohort, and 13%, 24%, and 33% (P = .002) in the validation cohort, respectively. The 5-year cumulative incidence of transplant-related mortality (TRM) was 5%, 14%, 27% (P < .0001) and 5%, 16%, 31% (P < .0001), respectively. The 5-year survival was 64%, 57%, 54% (P = .009) and 70%, 59%, 42% (P = .0008) in the 2 cohorts, respectively. In conclusion, Day100 score predicts cGVHD, TRM, and survival and, if validated in a separate group of patients, could be considered for trials of preemptive therapy.
format Online
Article
Text
id pubmed-9006267
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-90062672022-04-13 The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation Metafuni, Elisabetta Cavattoni, Irene Maria Lamparelli, Teresa Raiola, Anna Maria Ghiso, Anna Galaverna, Federica Gualandi, Francesca Di Grazia, Carmen Dominietto, Alida Varaldo, Riccardo Signori, Alessio Chiusolo, Patrizia Sora’, Federica Giammarco, Sabrina Laurenti, Luca Sica, Simona Angelucci, Emanuele Bacigalupo, Andrea Blood Adv Transplantation The aim of this study was to develop a predictive score for moderate-severe chronic graft-versus-host disease (cGVHD) on day +100 after allogeneic stem cell transplantation (HSCT). We studied 1292 patients allografted between 1990 and 2016, alive on day +100 after transplant, without cGVHD, and with full biochemistry laboratory values available. Patients were randomly assigned to a training and a validation cohort (ratio 1:1). In the training cohort, a multivariate analysis identified 4 independent predictors of moderate-severe cGVHD: gamma-glutamyl transferase ≥75 UI/l, creatinine ≥1 mg/dl, cholinesterase ≤4576 UI/l, and albumin ≤4 g/dl. A score of 1 was assigned to each variable, producing a low (0 to 1), intermediate (2 to 3), and high (4) score. The cumulative incidence of moderate-severe cGVHD was 12%, 20%, and 52% (P < .0001) in the training cohort, and 13%, 24%, and 33% (P = .002) in the validation cohort, respectively. The 5-year cumulative incidence of transplant-related mortality (TRM) was 5%, 14%, 27% (P < .0001) and 5%, 16%, 31% (P < .0001), respectively. The 5-year survival was 64%, 57%, 54% (P = .009) and 70%, 59%, 42% (P = .0008) in the 2 cohorts, respectively. In conclusion, Day100 score predicts cGVHD, TRM, and survival and, if validated in a separate group of patients, could be considered for trials of preemptive therapy. American Society of Hematology 2022-04-05 /pmc/articles/PMC9006267/ /pubmed/34920451 http://dx.doi.org/10.1182/bloodadvances.2021005675 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Transplantation
Metafuni, Elisabetta
Cavattoni, Irene Maria
Lamparelli, Teresa
Raiola, Anna Maria
Ghiso, Anna
Galaverna, Federica
Gualandi, Francesca
Di Grazia, Carmen
Dominietto, Alida
Varaldo, Riccardo
Signori, Alessio
Chiusolo, Patrizia
Sora’, Federica
Giammarco, Sabrina
Laurenti, Luca
Sica, Simona
Angelucci, Emanuele
Bacigalupo, Andrea
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
title The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
title_full The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
title_fullStr The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
title_full_unstemmed The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
title_short The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
title_sort day 100 score predicts moderate to severe cgvhd, transplant mortality, and survival after hematopoietic cell transplantation
topic Transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006267/
https://www.ncbi.nlm.nih.gov/pubmed/34920451
http://dx.doi.org/10.1182/bloodadvances.2021005675
work_keys_str_mv AT metafunielisabetta theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT cavattoniirenemaria theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT lamparelliteresa theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT raiolaannamaria theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT ghisoanna theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT galavernafederica theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT gualandifrancesca theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT digraziacarmen theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT dominiettoalida theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT varaldoriccardo theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT signorialessio theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT chiusolopatrizia theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT sorafederica theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT giammarcosabrina theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT laurentiluca theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT sicasimona theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT angelucciemanuele theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT bacigalupoandrea theday100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT metafunielisabetta day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT cavattoniirenemaria day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT lamparelliteresa day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT raiolaannamaria day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT ghisoanna day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT galavernafederica day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT gualandifrancesca day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT digraziacarmen day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT dominiettoalida day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT varaldoriccardo day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT signorialessio day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT chiusolopatrizia day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT sorafederica day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT giammarcosabrina day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT laurentiluca day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT sicasimona day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT angelucciemanuele day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation
AT bacigalupoandrea day100scorepredictsmoderatetoseverecgvhdtransplantmortalityandsurvivalafterhematopoieticcelltransplantation